Canada - English - Health Canada

homeocan inc. - platina homeo chemical - tablet - 4ch - platina homeo chemical 4ch - homeopathic products

Canada - English - Health Canada

boiron laboratoires - platina homeo chemical - tablet - 4ch - platina homeo chemical 4ch - homeopathic products

Canada - English - Health Canada

boiron laboratoires - platina homeo chemical - drops - 4ch - platina homeo chemical 4ch - homeopathic products

Canada - English - Health Canada

dolisos laboratoires s.a. - platina homeo chemical - tablet - 4ch - platina homeo chemical 4ch - homeopathic products

Canada - English - Health Canada

dolisos laboratoires s.a. - platina homeo chemical - drops - 3ch - platina homeo chemical 3ch - homeopathic products

Canada - English - Health Canada

thompson's homeopathic supplies ltd. - platina homeo chemical - drops - 3c - platina homeo chemical 3c - homeopathic products

Canada - English - Health Canada

seroyal international inc. - platinum - globules - 3x - platinum 3x - homeopathic products

Canada - English - Health Canada

dolisos canada inc. - platinum - globules - 3x - platinum 3x - homeopathic products

European Union - English - EMA (European Medicines Agency)

accord healthcare s.l.u. - docetaxel - head and neck neoplasms, carcinoma, non-small-cell lung, adenocarcinoma, prostatic neoplasms, breast neoplasms - antineoplastic agents, - breast cancerdocetaxel accord in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:operable node-positive breast cancer;operable node-negative breast cancer.for patients with operable node-negative breast cancer, adjuvant treatment should be restricted to patients eligible to receive chemotherapy according to internationally established criteria for primary therapy of early breast cancer.docetaxel accord in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.docetaxel accord monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.docetaxel accord in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer w

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eucogen sdn bhd - magnesium sulfate,heptahydrate -